The association of resilience and positive mental health in systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study.
Journal: Journal of psychosomatic research
Volume: 179
Issue:
Year of Publication:
Affiliated Institutions:
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada. Electronic address: marieke.neyer@mail.mcgill.ca.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada. Electronic address: richard.henry@mail.mcgill.ca.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Psychiatry, Centre for Mindfulness, Radboud University Medical Center, Nijmegen, the Netherlands.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: gabrielle.virgili-gervais@mail.mcgill.ca.
University of Rhode Island, Kingston, RI, USA. Electronic address: rwojeck@uri.edu.
School of Kinesiology, University of the Fraser Valley, Chilliwack, Canada. Electronic address: Amanda.Wurz@ufv.ca.
National Scleroderma Foundation, Tri-State Chapter, Binghamton, NY, USA.
National Scleroderma Foundation, Los Angeles, CA, USA.
Sclérodermie Québec, Longueuil, Quebec, Canada.
Scleroderma Australia, Melbourne, Victoria, Australia; Scleroderma Victoria, Melbourne, Victoria, Australia. Electronic address: president@sclerodermaaustralia.com.au.
University of Texas McGovern School of Medicine, Houston, TX, USA. Electronic address: Maureen.D.Mayes@uth.tmc.edu.
Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Paris, France; Assistance Publique Hôpitaux de Paris-Centre, Hôpital Cochin, Université Paris Cité, Paris, France. Electronic address: luc.mouthon@aphp.fr.
Department of Psychology, Western University, and Lawson Research Institute, London, Ontario, Canada.
Scleroderma Atlantic, Halifax, Nova Scotia, Canada.
Scleroderma Society of Ontario, Hamilton, Ontario, Canada; Scleroderma Canada, Hamilton, Ontario, Canada.
New York University, NY, New York, USA. Electronic address: daphna.harel@nyu.edu.
Department of Psychology, San Diego State University, San Diego, CA, USA; San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA. Electronic address: vmalcarne@sdsu.edu.
Department of Medicine, McGill University, Montreal, Quebec, Canada; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: susan.bartlett@mcgill.ca.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: andrea.benedetti@mcgill.ca.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. Electronic address: brett.thombs@mcgill.ca.
Abstract summary
A previous study using Scleroderma Patient-centered Intervention Network (SPIN) Cohort data identified five classes of people with systemic sclerosis (also known as scleroderma) based on patient-reported somatic (fatigue, pain, sleep) and mental health (anxiety, depression) symptoms and compared indicators of disease severity between classes. Across four classes ("low", "normal", "high", "very high"), there were progressively worse somatic and mental health outcomes and greater disease severity. The fifth ("high/low") class, however, was characterized by high disease severity, fatigue, pain, and sleep but low mental health symptoms. We evaluated resilience across classes and compared resilience between classes.Cross-sectional study. SPIN Cohort participants completed the 10-item Connor-Davidson-Resilience Scale (CD-RISC) and PROMIS v2.0 domains between August 2022 and January 2023. We used latent profile modeling to identify five classes as in the previous study and multiple linear regression to compare resilience levels across classes, controlling for sociodemographic and disease variables.Mean CD-RISC score (N = 1054 participants) was 27.7 (standard deviation = 7.3). Resilience decreased progressively across "low" to "normal" to "high" to "very high" classes (mean 4.7 points per step). Based on multiple regression, the "high/low" class exhibited higher resilience scores than the "high" class (6.0 points, 95% confidence interval [CI] 4.9 to 7.1 points; standardized mean difference = 0.83, 95% CI 0.67 to 0.98).People with worse disease severity and patient-reported outcomes reported substantially lower resilience, except a class of people with high disease severity, fatigue, pain, and sleep disturbance but positive mental health and high resilience.
Authors & Co-authors:
Neyer
Henry
Carrier
Kwakkenbos
Virgili-Gervais
Wojeck
Wurz
Gietzen
Gottesman
Guillot
Lawrie-Jones
Mayes
Mouthon
Nielson
Richard
Sauvé
Harel
Malcarne
Bartlett
Benedetti
Thombs
Study Outcome
Source Link: Visit source